PHMMF OTC
Pharma Mar, S.A.
1W: +0.0%
1M: +0.0%
3M: +19.0%
YTD: +9.7%
1Y: -7.5%
3Y: +193.2%
5Y: +10.3%
$94.60
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$53M
+781.2% ▲
5Y CAGR: -28.2%
Capital Expenditures
$9M
+39.6% ▲
5Y CAGR: +25.6%
Free Cash Flow
$44M
+561.2% ▲
5Y CAGR: -30.8%
Dividends Paid
$14M
-22.1% ▼
Buybacks
$18M
+2.4% ▲
Net Change in Cash
-$38M
-1279.1% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $95M | $44M | $1M | $12M | $75M |
| Depreciation & Amort. | $6M | $6M | $6M | $7M | $8M |
| Stock-Based Comp. | $339K | $393K | $297K | $0 | $0 |
| Change in Working Capital | -$61M | -$28M | -$35M | -$32M | -$7M |
| Other Non-Cash Items | $3M | $16M | $14M | $19M | -$23M |
| Operating Cash Flow | $26M | $38M | -$13M | $6M | $53M |
| — Investing Activities — | |||||
| Capital Expenditures | -$8M | -$9M | -$16M | -$15M | -$9M |
| Acquisitions (Net) | $0 | $11K | $0 | $0 | $0 |
| Investment Purchases | $0 | -$219M | -$314M | -$351M | -$51M |
| Investment Sales | $26M | $239M | $287M | $367M | $0 |
| Other Investing | $0 | $0 | $0 | $393K | $0 |
| Investing Cash Flow | $18M | $11M | -$43M | $1M | -$61M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$9M | -$9M | -$1M | $9M | -$4M |
| Stock Repurchased | -$41M | -$50M | -$38M | -$19M | -$18M |
| Dividends Paid | -$11M | -$12M | -$12M | -$11M | -$14M |
| Other Financing | $0 | $0 | $19M | -$3M | $0 |
| Financing Cash Flow | -$27M | -$13M | -$32M | -$5M | -$37M |
| Net Change in Cash | $17M | $36M | -$90M | $3M | -$38M |
| Cash End of Period | $113M | $150M | $60M | $63M | $18M |
| Free Cash Flow | $18M | $29M | -$29M | -$9M | $44M |